Tahmina Hassan, M.D. Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 5247 Didesse Dr, Baton Rouge, LA 70808 Phone: 225-765-3076 Fax: 225-765-3090 |
Oana M Petcu, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 Florida Blvd, Baton Rouge, LA 70806 Phone: 225-387-7070 Fax: 225-387-7700 |
Dr. Susan Ellen Nelson, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7436 Bishop Ott Dr, Baton Rouge, LA 70806 Phone: 225-490-0604 Fax: 225-490-0354 |
Dr. William Patrick Gahan, M.D. Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 5247 Didesse Dr, Baton Rouge, LA 70808 Phone: 225-765-3076 Fax: 225-765-3090 |
Dr. Edmond Franklin Tipton, M.D. Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 5247 Didesse Dr, Baton Rouge, LA 70808 Phone: 225-765-3076 Fax: 225-765-3090 |
News Archive
Their preliminary studies with the new test suggest a molecular signature exclusive to this deadly cancer, known for its ability to remain undetected and spread quickly.
EnGeneIC Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, today announced that the first patient has been dosed in its Phase 1 Tailored-EDV trial. The trial is being conducted at the Northern Cancer Institute in Sydney, Australia.
A class of medications commonly prescribed to lower blood sugar in diabetic patients appears to protect them from developing heart failure, according to a study at Henry Ford Hospital in Detroit.
High-altitude areas-; particularly the US intermountain states-; have increased rates of suicide and depression, suggests a review of research evidence in the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Previous research identified the interferon-responsive OAS1 gene as a risk gene for Alzheimer's disease. OAS1 is an enzyme that binds to double-stranded RNA and induces the conformation to create oligoadenylates. They also activate RNase L to break down RNA.
› Verified 9 days ago